CXCL2 and dermatitis: Oral propionate and the HFD reduced mRNA expression of IL-17A, IL-17C, IL-17F, IL-22, IL-1β, IL-6, TNF-α, CXCL1, CXCL2, and CCL20 in imiquimod-induced dermatitis.